Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Alzheimer's disease (AD) is characterized by dementia severity correlating with reduced synapse density in key brain regions.
• Soluble beta-amyloid (Aβ) oligomers are implicated in inhibiting hippocampal long-term potentiation (LTP), but the precise synaptic mechanisms are not fully understood.

Purpose of the Study:

• To investigate the synaptic mechanisms by which soluble Aβ oligomers affect synaptic plasticity in the hippocampus.
• To determine the role of astrocytic glutamate transporters in mediating the effects of Aβ on LTP and LTD.

Main Methods:

• Field excitatory postsynaptic potentials (fEPSP) were recorded in the CA1 region of mouse hippocampal slices.
• The effects of Aβ-containing medium and glutamate transporter inhibitors (DL-TBOA, TFB-TBOA) on LTP and LTD were assessed.
• Expression of astrocytic glutamate transporters (EAAT1, EAAT2) was analyzed in cultured astrocytes exposed to Aβ oligomers.

Main Results:

• Aβ oligomers inhibited LTP and facilitated LTD, shifting the LTP/LTD curve.
• These effects were mimicked by a non-selective glutamate transporter inhibitor and occluded by selective astrocytic glutamate transporter inhibitors.
• Aβ oligomers reduced the expression of astrocytic glutamate transporters (EAAT1, EAAT2) in cultured astrocytes.

Conclusions:

• Soluble Aβ oligomers impair synaptic plasticity by decreasing the activation of astrocytic glutamate transporters.
• This impaired transporter function leads to altered synaptic plasticity, contributing to cognitive deficits in Alzheimer's disease.